Nanalysis Scientific Corp.
NSCIF
$0.13
$0.016.08%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.82M | 30.83M | 32.30M | 33.19M | 31.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.82M | 30.83M | 32.30M | 33.19M | 31.62M |
| Cost of Revenue | 21.79M | 22.07M | 22.87M | 23.91M | 24.06M |
| Gross Profit | 8.04M | 8.76M | 9.43M | 9.28M | 7.55M |
| SG&A Expenses | 7.69M | 8.08M | 8.20M | 8.25M | 8.36M |
| Depreciation & Amortization | 2.69M | 2.89M | 2.97M | 3.18M | 3.14M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.51M | 33.41M | 34.32M | 35.74M | 35.85M |
| Operating Income | -2.68M | -2.58M | -2.02M | -2.54M | -4.23M |
| Income Before Tax | -8.85M | -8.98M | -8.88M | -9.87M | -5.37M |
| Income Tax Expenses | 4.60K | -4.80K | 15.40K | -15.60K | 725.50K |
| Earnings from Continuing Operations | -8.86 | -8.97 | -8.90 | -9.86 | -6.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | -8.86M | -8.97M | -8.90M | -9.86M | -6.09M |
| EBIT | -2.68M | -2.58M | -2.02M | -2.54M | -4.23M |
| EBITDA | -2.14M | -1.28M | -21.30K | 190.00K | -1.50M |
| EPS Basic | -0.08 | -0.08 | -0.08 | -0.09 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| EPS Diluted | -0.08 | -0.08 | -0.08 | -0.09 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 454.72M | 453.00M | 452.49M | 442.52M | 430.88M |
| Average Diluted Shares Outstanding | 454.72M | 453.00M | 452.49M | 442.52M | 430.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |